01
What changed in biotechnology regulation and policy this week?
Government decisions, new rules and policy shifts reported this week.
02
Senator Todd Young, chairman of the National Security Commission on Emerging Biotechnology, is advocating for a stronger U.S. biotech innovation ecosystem to counter China's growing influence in the sector.
Read at fiercebiotech.com ↗03
A bipartisan group of U.S. lawmakers introduced the Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act and the Protecting Biological Data Act on September 24, 2026.
Read at cyberscoop.com ↗04
Nine pharmaceutical industry leaders have issued a warning regarding the decline of the biotechnology sector in Europe compared to the U.S. and China.
Read at biopharmadive.com ↗05
Donald Trump has reversed his proposal to establish a commission with veto power over federal research grants awarded by the National Institutes of Health.
Read at nytimes.com ↗06
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved lurbinectedin (Zepzelca) on September 23, 2026, for treating adults with extensive-stage small cell lung cancer.
Read at gov.uk ↗07
President Donald Trump is planning to issue an executive order to increase political oversight of the National Institutes of Health (NIH).
Read at fiercebiotech.com ↗08
The European Medicines Agency (EMA) received 13 new drug filings as of September 17, 2026.
Read at citeline.com ↗8 of 11 regulation and policy events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What funding rounds and acquisitions happened in biotechnology this week?
The week’s notable investments, financing rounds, acquisitions and strategic deals.
09
Enveda, a biotech startup based in the United States, has raised $311 million in a Series E funding round led by Catalio Capital Management.
Read at techcrunch.com ↗10
Enveda Biosciences has raised $311 million in a Series E funding round.
Read at fiercebiotech.com ↗11
London-based Basecamp Research has raised $140 million in a Series C funding round led by S32.
Read at sifted.eu ↗12
On September 23, 2026, the biotechnology company Enveda Biosciences announced it is expanding its efforts to discover new drugs by utilizing artificial intelligence to analyze natural compounds.
Read at citeline.com ↗13
AbbVie has entered a multi-year partnership with Iambic to utilize AI models for drug discovery in immunology, neuroscience, and oncology.
Read at pharmexec.com ↗14
Telix Pharmaceuticals has entered into a definitive agreement to acquire ITM Isotope Technologies Munich for $1.65 billion in an upfront payment.
Read at fiercebiotech.com ↗15
Eli Lilly and Co. broke ground on a $6.5 billion manufacturing facility in Houston, Texas, on Monday, September 21, 2026.
Read at bisnow.com ↗16
The National Cancer Institute (NCI) introduced the Strategic Breakthrough Program, offering up to $30 million in funding for innovations targeting pediatric and rare cancers.
Read at bio.news ↗8 of 20 funding and m&a events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What products launched in biotechnology this week?
Notable product launches, releases and platform updates from the week.
17
Seattle-based biotech company Talus Bio has developed a new drug discovery model called Ptarmigan-1 that bypasses protein folding predictions.
Read at drugdiscoverytrends.com ↗18
NVIDIA researchers Faradawn Yang, Peter St John, Kyle Tretina, and Zoey Zhang introduced an optimized Mixture-of-Experts (MoE) training recipe for biological foundation models using the NVIDIA Transformer Engine.
Read at nvidia.com ↗19
Alexion Pharmaceuticals is planning to enter the generalized myasthenia gravis (gMG) treatment market with its drug candidate gefurulimab.
Read at citeline.com ↗20
NHS England has launched a pilot program for a rapid genomic test designed to accelerate the diagnosis of brain tumours.
Read at nhs.uk ↗21
Oracle announced the expansion of its Life Sciences Data Intelligence platform at the Oracle Health and Life Sciences Summit 2026 in Orlando, Florida, on September 23, 2026.
Read at fiercehealthcare.com ↗22
The National Library of Medicine, part of the U.S. National Institutes of Health (NIH), has launched a pilot version of a new digital tool.
Read at fiercebiotech.com ↗23
The US Food and Drug Administration (FDA) has granted approval to Cordis for its sirolimus drug-coated balloon.
Read at fiercebiotech.com ↗24
InnerPlant demonstrated the use of hyperspectral imaging to monitor its genetically modified glowing soybeans.
Read at payloadspace.com ↗8 of 11 product launches events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What financial results were reported in biotechnology this week?
Earnings, guidance and other financial results reported this week.
25
Adagio Medical has launched a strategic review of its business operations and announced a workforce reduction affecting more than 50% of its full-time employees.
Read at fiercebiotech.com ↗26
Iambic Therapeutics is preparing for an initial public offering (IPO) following a recent funding round and several partnerships with major pharmaceutical companies.
Read at fiercebiotech.com ↗2 of 4 financial results events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What court rulings and legal actions hit biotechnology this week?
Court rulings, filings and legal actions reported this week.
27
A jury in the Northern District of California awarded Nektar Therapeutics $90 million in damages after finding that Eli Lilly breached a covenant of good faith in their collaboration agreement for the drug candidate rezpegaldesleukin.
Read at genengnews.com ↗28
Johnson & Johnson secured a patent victory for its depression drug Spravato, which uses esketamine.
Read at pharmavoice.com ↗What research was published in biotechnology this week?
New research findings and studies published this week.
29
Researchers led by Jian Li at Harvard Medical School identified that silencing the ALDH3B2 gene in human pancreatic ductal cells increases their conversion into insulin-producing beta-like cells from less than 1 percent to approximately 8.5 percent.
Read at wired.com ↗30
Scientists have successfully cloned a mouse and subsequently cloned the resulting clone in a multi-generational experiment.
Read at futurism.com ↗31
AbbVie is developing a trispecific antibody, ABBV-2001, targeting multiple myeloma.
Read at citeline.com ↗32
Researchers at the NYU Langone Transplant Institute have been recognized for their work in xenotransplantation, specifically the use of gene-edited pig organs for human patients.
Read at gizmodo.com ↗33
Researchers at Stanford University published a paper in Nature Neuroscience on September 24, 2026, suggesting the human brain consists of two distinct organs that evolved independently.
Read at futurism.com ↗34
Anthropic announced that its AI model Claude autonomously discovered a previously uncharacterized enzyme system in bacteriophages.
Read at theverge.com ↗35
Anthropic CEO Dario Amodei predicted on Wednesday, September 23, 2026, that artificial intelligence could help cure most major diseases within the next five to ten years.
Read at foxbusiness.com ↗36
Viking Therapeutics reported trial data on September 22, 2026, showing that its experimental obesity drug VK2735 achieved 21.7% weight loss at 33 weeks without plateauing.
Read at thestreet.com ↗8 of 43 research events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What incidents and outages hit biotechnology this week?
Incidents, outages and safety events reported this week.
37
Xenon Pharmaceuticals shares fell 30% on September 18, 2026, following a temporary pause in new patient enrollment for its depression trials of the drug azetukalner due to adverse neuropsychiatric events.
Read at thestreet.com ↗What partnerships were announced in biotechnology this week?
Partnerships, integrations and joint projects announced this week.
38
Thar Process, a Pittsburgh-based supercritical fluid technology company, has partnered with the French firm ExtrateX to distribute its Isolator SFC systems across Europe.
Read at genengnews.com ↗39
Genialis and Inventia Life Science have entered a partnership to integrate AI-powered patient insights with 3D cell model platforms to improve pancreatic cancer treatment testing.
Read at genengnews.com ↗40
Canadian agritech company Crush Dynamics has partnered with AI developer Atomic47 Labs to optimize its fermentation process for food ingredients.
Read at foodnavigator.com ↗41
The Business Group on Health has partnered with the biological intelligence firm BioRadar to provide employers with AI-powered tools for monitoring emerging biological threats.
Read at fiercehealthcare.com ↗42
Mayo Clinic and Thermo Fisher Scientific have announced a partnership to establish a new company named Precure.
Read at healthcaredive.com ↗5 of 11 partnerships events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.
What people moved in and out of biotechnology roles this week?
Executive appointments and departures reported this week.
43
Julien Elric has been appointed as the new senior investment director at Servier Ventures, the corporate venture capital arm of the French pharmaceutical company Servier.
Read at globalventuring.com ↗What else happened in biotechnology this week?
Developments from the week that fit none of the other sections.
44
The pharmaceutical industry is shifting focus toward oral peptide-based drugs.
Read at wsj.com ↗45
Pharmaceutical companies are facing a significant talent shortage as they reshore manufacturing operations to the United States, with competition for skilled workers intensifying due to demand from data centers.
Read at biospace.com ↗2 of 14 other developments events are listed; the rest were ranked lower by importance and multi-source corroboration and are not shown.